| Dec 1, 2014
| 2:49 AM
There's yet another pharmaceutical campaign on the offensive, hoping to convince women with sexual problems that a drug called Flibanserin will cure them. This compound is a central nervous system formula originally studied as a remedy for depression....
| Dec 10, 2014
| 2:30 AM
Trying to save money on prescription drugs can be enough to make you reach for the pain pills. Navigating the annual changes to your health plan, figuring out insurance co-pays, and finding the pharmacy with the best buys can be daunting. And if you're on...
| Nov 24, 2014
| 6:41 PM
— Wall Street's big business — helping companies buy other companies — is hotter than it's been in years.
When pharmaceuticals giant Actavis said it was buying Allergan Inc. in Irvine and Halliburton said it would take over rival oil-...
| Nov 16, 2014
| 6:08 PM
Arrowhead Research Corp. is trying to succeed where major pharmaceutical company efforts have failed in finding a cure for one of the world's most tenacious diseases.
The Pasadena biopharmaceutical company is developing so-called RNAi therapeutics. Such...
| Nov 17, 2014
Twenty years ago Jeff Baker started a promotional product company in a spare bedroom in his home in Indianapolis.
Today, that business, called Noble, has turned into a privately held multimillion-dollar niche product manufacturing company that takes...
| Nov 17, 2014
| 8:30 PM
Botox maker Allergan Inc., an Irvine company that started as a purveyor of eye drops and grew into one of the most respected pharmaceutical companies in the country, agreed to be acquired by Irish firm Actavis for $66 billion.
The deal thwarts a...
| Nov 18, 2014
| 3:18 PM
Ingredion said Tuesday its annual sales should hit $8 billion by 2019, up from $6.33 billion last year, as the ingredients-maker pushes to notch more sales from fast-growing specialty products and international markets.
The announcement comes weeks after...
| Oct 28, 2014
| 6:56 PM
Attorneys for Botox maker Allergan Inc. asked a federal judge in Santa Ana on Tuesday to prohibit activist investor Bill Ackman's hedge fund from voting in a shareholder election that could decide a hotly contested takeover effort.
At issue is a $50-...
| Nov 3, 2014
| 12:12 PM
Botox maker Allergan Inc., which has been fighting an unsolicited takeover bid from a Canadian pharmaceutical maker for six months, said in a regulatory filing that a second company is interested in buying it.
Allergan did not identify the new...
| Nov 4, 2014
| 10:12 AM
The Oklahoma Supreme Court on Tuesday temporarily put on hold a state law restricting abortions while the issue is argued in a lower court.
The unanimous action by the high court means that women in Oklahoma can continue to use the prescription drugs...
| Nov 4, 2014
| 11:35 AM
Botox maker Allergan Inc. lost its bid to prohibit activist investor Bill Ackman's hedge fund from voting in a shareholder election that could decide a hotly contested takeover effort.
Allergan had accused Ackman's Pershing Square Capital Management...